Flurina Böhi

机构：University of Zurich, Life Science Zurich · ORCID：0009-0002-1752-8437

发表论文 13 篇 · 总被引 117 次 · h-index 4

代表论文

• PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis (2023 · Proceedings of the National Academy of Sciences · 被引 43)
• A rationally designed oral vaccine induces immunoglobulin A in the murine gut that directs the evolution of attenuated Salmonella variants (2021 · Nature Microbiology · 被引 43)
• Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma (2023 · Cancer Research · 被引 20)
• Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation (2024 · Biomedicines · 被引 7)
• A rationally designed oral vaccine induces Immunoglobulin A in the murine gut that directs the evolution of attenuated Salmonella variants (2019 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Rationally designed oral vaccines can set an evolutionary trap for Salmonella Typhimurium (2019 · edoc (University of Basel) · 被引 1)